vs
安博教育（AMBO）与DBV Technologies S.A.（DBVT）财务数据对比。点击上方公司名可切换其他公司
DBV Technologies S.A.的季度营收约是安博教育的1.0倍（$2.8M vs $2.8M），安博教育净利率更高（64.2% vs -1195.5%，领先1259.7%），DBV Technologies S.A.同比增速更快（158.8% vs 15.3%）
安博教育控股有限公司是聚焦中国市场的教育服务提供商，业务涵盖K12课外辅导、职业技能培训、个性化学习方案定制等领域，依托数字技术与院校、企业开展合作，为全年龄段学习者提供优质教育资源。
DBV Technologies是一家总部位于法国巴涅的公开上市生物制药企业，核心研发成果为Viaskin给药技术，可在不进入血液循环的前提下，让过敏原或抗原作用于完整皮肤。其花生过敏疗法Viaskin Peanut的临床开发，已获得美国食品药品监督管理局授予快速通道资格。
AMBO vs DBVT — 直观对比
营收规模更大
DBVT
是对方的1.0倍
$2.8M
营收增速更快
DBVT
高出143.5%
15.3%
净利率更高
AMBO
高出1259.7%
-1195.5%
损益表 — Q2 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $2.8M | $2.8M |
| 净利润 | $1.8M | $-33.2M |
| 毛利率 | 53.3% | — |
| 营业利润率 | 11.9% | -1235.7% |
| 净利率 | 64.2% | -1195.5% |
| 营收同比 | 15.3% | 158.8% |
| 净利润同比 | 1343.1% | -8.9% |
| 每股收益（稀释后） | $0.03 | $-0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AMBODBVT
| Q3 25 | — | $2.8M | ||
| Q2 25 | $2.8M | $1.5M | ||
| Q2 24 | $2.4M | $1.2M | ||
| Q1 24 | — | $1.4M | ||
| Q4 23 | — | $8.9M | ||
| Q3 23 | — | $2.4M | ||
| Q2 23 | $2.7M | $2.3M | ||
| Q1 23 | — | $2.2M |
净利润AMBODBVT
| Q3 25 | — | $-33.2M | ||
| Q2 25 | $1.8M | $-41.9M | ||
| Q2 24 | $123.0K | $-33.1M | ||
| Q1 24 | — | $-27.3M | ||
| Q4 23 | — | $134.3M | ||
| Q3 23 | — | $-16.7M | ||
| Q2 23 | $-1.0M | $-24.2M | ||
| Q1 23 | — | $-20.6M |
毛利率AMBODBVT
| Q3 25 | — | — | ||
| Q2 25 | 53.3% | — | ||
| Q2 24 | 55.6% | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | 44.7% | — | ||
| Q1 23 | — | — |
营业利润率AMBODBVT
| Q3 25 | — | -1235.7% | ||
| Q2 25 | 11.9% | -2806.2% | ||
| Q2 24 | 2.7% | -2914.9% | ||
| Q1 24 | — | -2029.7% | ||
| Q4 23 | — | -134.3% | ||
| Q3 23 | — | -770.2% | ||
| Q2 23 | -27.7% | -1096.0% | ||
| Q1 23 | — | -964.7% |
净利率AMBODBVT
| Q3 25 | — | -1195.5% | ||
| Q2 25 | 64.2% | -2858.4% | ||
| Q2 24 | 5.1% | -2852.4% | ||
| Q1 24 | — | -1943.5% | ||
| Q4 23 | — | 1512.8% | ||
| Q3 23 | — | -705.6% | ||
| Q2 23 | -36.7% | -1059.6% | ||
| Q1 23 | — | -937.1% |
每股收益（稀释后）AMBODBVT
| Q3 25 | — | $-0.24 | ||
| Q2 25 | $0.03 | $-0.31 | ||
| Q2 24 | $0.00 | $-0.34 | ||
| Q1 24 | — | $-0.28 | ||
| Q4 23 | — | $-0.11 | ||
| Q3 23 | — | $-0.17 | ||
| Q2 23 | $-0.02 | $-0.26 | ||
| Q1 23 | — | $-0.22 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $4.1M | $69.8M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $8.6M | $52.9M |
| 总资产 | $23.2M | $110.5M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资AMBODBVT
| Q3 25 | — | $69.8M | ||
| Q2 25 | $4.1M | $103.2M | ||
| Q2 24 | $1.6M | $66.2M | ||
| Q1 24 | — | $101.5M | ||
| Q4 23 | — | $141.4M | ||
| Q3 23 | — | $149.1M | ||
| Q2 23 | $6.9M | $174.0M | ||
| Q1 23 | — | $192.3M |
股东权益AMBODBVT
| Q3 25 | — | $52.9M | ||
| Q2 25 | $8.6M | $86.2M | ||
| Q2 24 | $6.6M | $79.1M | ||
| Q1 24 | — | $111.7M | ||
| Q4 23 | — | $140.2M | ||
| Q3 23 | — | $144.0M | ||
| Q2 23 | $7.4M | $164.2M | ||
| Q1 23 | — | $179.1M |
总资产AMBODBVT
| Q3 25 | — | $110.5M | ||
| Q2 25 | $23.2M | $143.4M | ||
| Q2 24 | $17.6M | $114.2M | ||
| Q1 24 | — | $145.9M | ||
| Q4 23 | — | $183.0M | ||
| Q3 23 | — | $189.8M | ||
| Q2 23 | $28.8M | $217.5M | ||
| Q1 23 | — | $232.9M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $-32.4M |
| 自由现金流经营现金流 - 资本支出 | — | $-32.6M |
| 自由现金流率自由现金流/营收 | — | -1173.5% |
| 资本支出强度资本支出/营收 | — | 4.2% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-138.3M |
8季度趋势，按日历期对齐
经营现金流AMBODBVT
| Q3 25 | — | $-32.4M | ||
| Q2 25 | — | $-33.9M | ||
| Q2 24 | — | $-35.1M | ||
| Q1 24 | — | $-34.7M | ||
| Q4 23 | — | $-13.7M | ||
| Q3 23 | — | $-19.6M | ||
| Q2 23 | — | $-25.6M | ||
| Q1 23 | — | $-20.8M |
自由现金流AMBODBVT
| Q3 25 | — | $-32.6M | ||
| Q2 25 | — | $-33.9M | ||
| Q2 24 | — | $-35.8M | ||
| Q1 24 | — | $-36.0M | ||
| Q4 23 | — | $-14.0M | ||
| Q3 23 | — | $-19.6M | ||
| Q2 23 | — | $-25.7M | ||
| Q1 23 | — | $-21.0M |
自由现金流率AMBODBVT
| Q3 25 | — | -1173.5% | ||
| Q2 25 | — | -2316.5% | ||
| Q2 24 | — | -3084.0% | ||
| Q1 24 | — | -2560.6% | ||
| Q4 23 | — | -158.2% | ||
| Q3 23 | — | -827.3% | ||
| Q2 23 | — | -1124.0% | ||
| Q1 23 | — | -955.0% |
资本支出强度AMBODBVT
| Q3 25 | — | 4.2% | ||
| Q2 25 | — | 2.2% | ||
| Q2 24 | — | 63.0% | ||
| Q1 24 | — | 94.9% | ||
| Q4 23 | — | 4.0% | ||
| Q3 23 | — | 2.1% | ||
| Q2 23 | — | 7.2% | ||
| Q1 23 | — | 5.1% |
现金转化率AMBODBVT
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | -0.10× | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — | ||
| Q1 23 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
